Richard A Fair - President and CEO, Bellicum Pharmaceuticals, Inc

As of August 16, 2021


Richard A Fair Net Worth

  • Net worth is estimated to be at least $83.5K
  • Owns at least 11,813 units of Bellicum Pharmaceuticals, Inc stock

Richard A Fair Compensation at Bellicum Pharmaceuticals, Inc in 2020

  • Earned a $625,910 salary
  • Received a total compensation of $2,682,945

Richard A Fair Trading

  • Largest purchase of shares was 40,000 units , worth over $50K on September 11, 2019
  • In total has made about 7 transactions over 4 years
  • Usually trades in February, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Richard A Fair Mailing Address

  • Mailing address is C/o Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030 TX

Bellicum Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Richard A. Fair, 2020 $625,910 - $1,786,412 $249,190 $21,433 $2,682,945
Richard A. Fair, 2019 $566,204 - $1,021,004 $127,990 $17,690 $1,732,888
Atabak Mokari, 2020 $408,373 $163,764 $542,889 - $536,708 $1,651,734
Atabak Mokari, 2019 $375,000 - $669,168 $61,500 $2,233 $1,107,901
Shane M. Ward, 2020 $407,752 $164,114 $412,193 - $552,275 $1,536,334
Shane M. Ward, 2019 $374,062 - $153,151 $61,705 $17,941 $606,859
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1358403/000119312521141608/d176237ddef14a.htm

Bellicum Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 5,000 units bought on March 19, 2020 by Richard A Fair worth over $20K
  • In the last 5 years, insiders at Bellicum Pharmaceuticals, Inc sold an estimated value of $18.67M and bought an estimated value of $2.85M
  • The most active traders are David Spencer, Chief Technology Officer,  Kevin Slawin, Director,  and Alan A Musso, CFO and Treasurer
  • Insider trading is most common in June, with the busiest year in 2016

BELLICUM PHARMACEUTICALS, INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1